Business Wire

NY-VIACOMCBS

20.10.2020 14:47:11 CEST | Business Wire | Press release

Share
Pierluigi Gazzolo to Leave ViacomCBS Networks International

ViacomCBS Networks International (VCNI), a division of ViacomCBS Inc. (NASDAQ: VIAC), has today confirmed the departure of one of its longest serving executives, Pierluigi Gazzolo, who will step down from his role as President, Streaming and Studios for VCNI at the end of this month to focus on other interests.

During Gazzolo’s tenure as President of Streaming and Studios for VCNI, he successfully established the content proposition, team and go to market strategy for the international launch of Paramount+ and expanded the roadmap for Pluto TV internationally.

VCNI Streaming Leadership

Reporting to David Lynn, President and CEO of VCNI, and working closely with Tom Ryan, President & CEO of ViacomCBS Streaming, Kelly Day, Chief Operating Officer of VCNI, will take over leadership of the division’s streaming business as President of Streaming and COO of VCNI. In this new role, Day will have oversight of the international roll-out of Paramount+, a new premium SVOD service due to launch in 2021 across Australia, Latin America, and the Nordics; as well as the ongoing expansion of Pluto TV, following its successful launch in Latin America.

Regarding Day’s expanded remit, Lynn added, “We are in the fortunate position of going from strength to strength with this transition. With a truly global streaming organization, it’s a pivotal moment in the evolution of our streaming strategy, with the expansion of Paramount+ and Pluto TV, both of which are critical to our future growth. Kelly has an enviable track record of launching and growing streaming businesses and has added a layer of extraordinary digital expertise to our management team in a short space of time. Now, also, working closely with Tom Ryan, I’m confident Kelly will accelerate our transition to becoming a more digitally-led business, while seizing our global streaming opportunity.”

ViacomCBS International Studios Leadership

ViacomCBS Studios International (VIS) will supply original content to the new Paramount+ service in some markets, while continuing to supply scripted, comedy and reality series to VCNI’s free and pay TV networks as well as third party streamers and broadcasters.

Also, reporting to Lynn, JC Acosta, who oversees VCNI’s operations in Latin America and Canada as President, VCN Americas, will take on additional responsibility as President, ViacomCBS International Studios.

Lynn added, “One of our biggest achievements in recent years has been the formation and expansion of VIS, which really couldn’t have happened without Pier’s vision. In the past year, under Pier’s leadership he doubled the global development slate, setting VCNI up for continued global success in the studios arena.”

“Now with JC’s expertise in production and development, coupled with his drive and dedication its incredibly reassuring that JC will take over leadership of VIS,” said Lynn. “Given JC’s intimate understanding of our Studios business, his connections and his knowledge of the international content market, we couldn’t be better positioned for continued growth.”

Gazzolo’s Tenure

Paying tribute to Gazzolo, Lynn said, “While he will hate to be labelled as a veteran, there’s no better word to describe someone who has dedicated so much of his career to our company and who has benefited it so much with his wisdom and experience. He’s a brilliant all-rounder who has played in many positions for our team, but always with the same outstanding results. It’s typical of Pier’s commitment that he’s stayed to oversee a seamless handover to Kelly and JC, even though he’s been signaling his interest in pursuing his own projects for some time. I can’t thank him enough for his contribution to our business over many years. I know everyone at VCNI will join me in genuinely wishing him well in his future endeavors.”

Gazzolo commented, “I’ve grown up with this amazing company. From MTV Latino, to MTV Networks to Viacom International Media Networks to post merger ViacomCBS Networks International. I’ve been honored to grow and evolve with ViacomCBS, and I’m immensely grateful to have worked across so many regions and divisions at the most dynamic media company in the world. I have benefited tremendously from having worked with unparalleled leaders and mentors, throughout my tenure, but especially in the latest chapter of my term. Most importantly I’ve created wonderful close friendships in my 27 years with the company – and those will continue long after I leave the building.”

About Pierluigi Gazzolo

Prior to taking up his current role as President, Streaming and Studios in November 2019, Pierluigi Gazzolo was President, Americas for Viacom International Media Networks, which was renamed as VCNI after the ViacomCBS merger in December last year.

Based in Miami, he oversaw a marked expansion of the company’s operations across Spanish-speaking Latin America and Brazil, spearheaded by two key acquisitions – ownership of Argentina’s leading free-to-air broadcaster, Telefe (2016), and a majority stake in Brazilian comedy producer, Porta dos Fundos (2017). Combining Telefe’s studios business and Porta dos Fundos with VIMN’s existing production activities in the region, Gazzolo formed VIS and secured its first sales to both Netflix and Amazon Prime, as well as a host of other deals with broadcasters and streamers across the region. Under his leadership, VIS has expanded its production activities in the UK, Europe, and Asia.

At the same time as leading the company’s operations in Latin America, Gazzolo continued to lead Nickelodeon internationally, giving him oversight of this critical brand in all markets outside the U.S. In this role, he oversaw an increase in international supply to Nickelodeon’s global content pipeline with locally developed shows being remade for global distribution, including Talia in the Kitchen and Every Witch Way.

Previously, Gazzolo was Chief Operating Officer for VIMN (2011 to 2014) and its predecessor MTV Networks International (2009 to 2011), reporting in both roles to Bob Bakish, who is now CEO, ViacomCBS Inc. Before 2009, he held several different roles with the company including serving as President of MTV Networks Latin America.

ViacomCBS Networks International:

ViacomCBS Networks International, a unit of ViacomCBS Inc. (NASDAQ: VIAC), comprises many of the world’s most iconic entertainment brands, including Network 10, Channel 5, Telefe, Viacom 18, ViacomCBS International Studios, Nickelodeon, MTV, Comedy Central, BET, Paramount Network and Pluto TV. In addition to offering innovative streaming services and digital video products, ViacomCBS Networks International provides powerful capabilities in production, distribution and advertising solutions for partners on five continents and across more than 180 countries.

VIAC-IR

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye